Cite

HARVARD Citation

    Pratley, R. et al. (2021). An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg. Diabetes, obesity & metabolism. 23 (11), pp. 2513-2520. [Online]. 
  
Back to record